Reduced Exploration, Increased Anxiety, and Altered Social Behavior: Autistic-like Features of Euchromatin Histone Methyltransferase 1 Heterozygous Knockout Mice
Overview
Psychology
Social Sciences
Authors
Affiliations
The 9q34.3 subtelomeric deletion syndrome is a newly defined mental retardation syndrome, caused by haplo-insufficiency of the euchromatin histone methyltransferase 1 (EHMT1) gene. Patients also have childhood hypotonia, facial dysmorphisms, delay in reaching developmental milestones, and behavioral problems like aggressive outbursts, hypoactivity, or autistic-like features. Male and female heterozygous Ehmt1 knockout mice (Ehmt1(+/-), aged 1-20 months, kept on a C57BL/6J background), were used to investigate whether they mimic the patients behavioral characteristics by comparing their behavior to wildtype littermates. The Ehmt1(+/-) mice revealed reduced activity and exploration, with increased anxiety compared to wildtype mice when exposed to novel environments in the open field, object exploration, marble burying, light-dark box, mirrored chamber and T-maze tests. They also demonstrated diminished social play when encountering a mouse from a different litter, and a delayed or absent response to social novelty when exposed to a stranger mouse. However, no differences in phenotyper home cage locomotor activity or rotarod motor function were observed between Ehmt1(+/-) and wildtype mice. Together, these results indicate that the hypoactivity and the autistic-like features of 9q34.3 subtelomeric deletion syndrome patients are recapitulated in this Ehmt1(+/-) mouse model, and that the hypoactivity is apparently not caused by any motor dysfunction. Together, these observations make it plausible that the Ehmt1(+/-) mouse is a faithful mammalian model for the autistic-like behavioral features of patients with the 9q34.3 subtelomeric deletion syndrome.
Balogh A, Bodi-Jakus M, Karl V, Bellak T, Szeky B, Farkas J Sci Rep. 2024; 14(1):22572.
PMID: 39343771 PMC: 11439915. DOI: 10.1038/s41598-024-72791-4.
Social and emotional alterations in mice lacking the short dystrophin-gene product, Dp71.
Miranda R, Ceschi L, Le Verger D, Nagapin F, Edeline J, Chaussenot R Behav Brain Funct. 2024; 20(1):21.
PMID: 39182120 PMC: 11344925. DOI: 10.1186/s12993-024-00246-x.
Advances in animal models of prenatal opioid exposure.
Ferrante J, Blendy J Trends Neurosci. 2024; 47(5):367-382.
PMID: 38614891 PMC: 11096018. DOI: 10.1016/j.tins.2024.03.005.
OConnor M, Qiao H, Odamah K, Cerdeira P, Man H Heliyon. 2024; 10(3):e24703.
PMID: 38322873 PMC: 10844029. DOI: 10.1016/j.heliyon.2024.e24703.
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder.
Zarate-Lopez D, Torres-Chavez A, Galvez-Contreras A, Gonzalez-Perez O Curr Neuropharmacol. 2023; 22(2):260-289.
PMID: 37873949 PMC: 10788883. DOI: 10.2174/1570159X22666231003121513.